HaDEA has signed two new contracts under the 2024 EU4Health work programme.
Professionals and staff from competent authorities or delegated bodies will be trained in the field of organ transplant practices to strengthen their organ donation and transplantation systems.
HaDEA and DG SANTE have prepared video guidelines for the EU4Health call for tenders HADEA/2025/OP/0045 - Single Framework contract for supporting joint work of Member States in the field of Substances of Human Origin.
The scope of the call for tenders is to prepare SoHO professionals across the EU for the 2027 implementation of the Regulation on Substances of Human Origin.
The scope of the upcoming call for tenders will be to prepare SoHO professionals across the EU for the 2027 implementation of the Regulation (EU) 2024/1938 on Substances of Human Origin.
The objective of this framework contract is to support the new EU rules in the continued provision of SoHO therapies, based on high standards of safety and quality and up-to-date technical rules.
This call for tenders is a service contract for administrative and secretarial support in managing the groups and governance bodies contributing to the implementation and operation of the European Health Data Space (EHDS) Regulation and other digital health initiatives.
The objective of this framework contract is to support the new EU rules in the continued provision of SoHO therapies, based on high standards of safety and quality and up-to-date technical rules.
This call for tenders is a service contract for administrative and secretarial support in managing the groups and governance bodies contributing to the implementation and operation of the European Health Data Space (EHDS) Regulation and other digital health initiatives.
This call aims to conclude multiple framework contracts in cascade for the provision of legal support services in the field of compliance assessment of national transposing measures, in the health and food safety areas in the context of the enlargement.
This call aims to speed up the development of next generation influenza vaccines that could be produced in rapidly scalable manufacturing platforms, could support products utilising novel administration routes, confer mucosal immunity, target potentially pandemic influenza A viruses or could be rapidly adapted to pandemic influenza A viruses.
The objective of this call for tenders is to strengthen the scientific evidence on the immunity provided by the Modified Vaccinia Ankara virus-Bavarian Nordic (MVA-BN) vaccine, with particular emphasis on the need and optimal timing of booster doses.
This call for tenders aims to speed up the development of a point-of-care diagnostic medical device that can provide antimicrobial susceptibility testing (AST) results on the bacteria or fungi causing an infection in humans, within one hour or less from sample collection, and ideally, to also allow for pathogen identification.
This call for tenders will aim to support activities to strengthen the capacities of EU countries in implementing the Regulation on standards for quality and safety of substances of human origin intended for human application.
This call for tenders aims at supporting key stakeholders to comply with the EHDS requirements and technical specifications, while supporting their collaboration in the rollout and operations of HealthData@EU.
The call aims to purchase horizon scanning in the area of medical devices and in vitro diagnostic medical devices in order to maintain an up to date overview of new and emerging technologies.
This action will aim at supporting key stakeholders to comply with the European Health Data Space (EHDS) requirements and technical specifications. Possible publication: November.
This action will aim to facilitate the use of European harmonised medical device nomenclatures (EMDN) and the International medical device regulators forum’s adverse event (IMDRF AE) terminologies by all stakeholders. Publication upcoming.
This action will aim to facilitate the use of European harmonised medical device nomenclatures (EMDN) and the International medical device regulators forum’s adverse event (IMDRF AE) terminologies by all stakeholders. Publication upcoming.
The call aims to procure timely and high-quality services to ensure the contracting authority's access to sector-specific data and specialised economic expertise on medical products to support policy decision making.
